Operating Income
Thermo Fisher Scientific Operating Income increased by 8.6% to $1.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $1.72B to $1.86B. Over 3 years (FY 2021 to FY 2024), Operating Income shows a downward trend with a -9.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Growth in operating income suggests that the core business is becoming more profitable and efficient.
Detailed definition
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
Peer comparison
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
operating_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.16B | $2.28B | $2.54B | $2.82B | $2.00B | $1.71B | $1.86B | $1.56B | $1.58B | $1.86B | $1.85B | $1.66B | $1.82B | $1.84B | $2.02B | $1.72B | $1.86B |
| QoQ Change | — | +5.3% | +11.4% | +11.2% | -29.1% | -14.5% | +8.8% | -16.0% | +1.0% | +18.1% | -0.5% | -10.3% | +9.4% | +1.0% | +9.7% | -14.9% | +8.6% |
| YoY Change | — | — | — | — | -7.5% | -24.9% | -26.7% | -44.6% | -21.1% | +9.0% | -0.4% | +6.4% | +15.3% | -1.4% | +8.7% | +3.2% | +8.6% |
Business Segments
| Segment | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Life Sciences Solutions | $895.00M | $840.00M | $865.00M | $845.00M | $953.00M | $834.00M | $968.00M | $954.00M |
| Laboratory Products and Biopharma Services | — | — | — | — | — | — | $868.00M | $778.00M |
| Analytical Instruments | $587.00M | $400.00M | $439.00M | $451.00M | $665.00M | $399.00M | $429.00M | $355.00M |
| Specialty Diagnostics | $264.00M | $294.00M | $299.00M | $293.00M | $273.00M | $304.00M | $321.00M | $313.00M |
| Laboratory Productsand Services | $804.00M | $744.00M | $745.00M | $773.00M | — | — | — | — |
| Total | $1.85B | $1.66B | $1.82B | $1.84B | $2.02B | $1.72B | — | $1.86B |
Laboratory Productsand Services was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Operating Income at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's operating income?
- Thermo Fisher Scientific (TMO) reported operating income of $1.86B in Q1 2026.
- How has Thermo Fisher Scientific's operating income changed year-over-year?
- Thermo Fisher Scientific's operating income increased by 8.6% year-over-year, from $1.72B to $1.86B.
- What is the long-term trend for Thermo Fisher Scientific's operating income?
- Over 3 years (2021 to 2024), Thermo Fisher Scientific's operating income has grown at a -9.9% compound annual growth rate (CAGR), from $10.03B to $7.34B.
- What does operating income mean?
- The profit earned from core business activities, before accounting for interest and taxes.